Mitigating Medical Device Risk through Human Factors. Christina Mendat, PhD Director, Research & Human Factors

Size: px
Start display at page:

Download "Mitigating Medical Device Risk through Human Factors. Christina Mendat, PhD Director, Research & Human Factors"

Transcription

1 Mitigating Medical Device Risk through Human Factors Christina Mendat, PhD Director, Research & Human Factors

2 A profound statistic one-third of medical device incidents involve user error and more than half of device recalls for design problems involve the user interface FDA spokesperson 2005 Who wants to have a product on the market that is used correctly 60% of the time?

3 So, what is Human Factors? A multidisciplinary field including: Learning & Behavior Cognitive Psychology Sensation & Perception Statistics Experimental Design Anthropometrics & Biomechanics Industrial Design Human Computer Interaction Ultimate Goal of Human Factors is to understand user interactions with product and systems to optimize the user experience and overall system performance.

4 How is Human Factors Unique? Beyond perceptions and attitudes. Multiple scientific-driven methodologies Analysis at multiple stages in the design process. Providing concrete and actionable design inputs.

5 Where else is Human Factors leveraged? Government and consumer sectors of industry have been incorporating human factors for many years: Aviation Transportation Telecommunication Continues to be the trend, in other industries to take a retroactive approach to Human Factors. Validation Testing after Tooling Focus groups after Tooling Risk Mitigation is best accomplished when involved Human Factors early and iteratively.

6 Movement of HF in Medical Devices Human Factors has received more attention from the medical community with the release of AAMI s standard: HE75 Good resource for Pharma Equipment developers. Key point is the importance of risk mitigation and the involvement of human factors early in the design process. Many industries can benefit from this standard.

7 Standards for HF are not completely new Code of Federal Regulations (Section ) (c) Design input Each manufacturer shall establish and maintain procedures to ensure that the design requirements relating to a device are appropriate and address the intended use of the device, including the needs of the users and patient. (d)design output Each manufacturer shall establish and maintain procedures for defining and documenting design output in terms that allow an adequate evaluation of conformance to design input requirements. (g)design validation Design validation shall ensure that devices conform to defined user needs and intended uses and shall include testing of production units under actual or simulated use conditions.

8 But the product works Technical functionality does not guarantee user functionality. Technical functionality does not prevent use errors. Users will do things with your product you never expected. Predicate devices don t guarantee risk mitigation. Instructions for use don t guarantee risk mitigation.

9 Mitigating Risk One Step at a Time

10 User-Centered Risk Mitigation The The user-centered old way of mitigating way of mitigating risk. risk.

11 Design Controls (no HF integration) Design Review (FRM0023) Design Review (FRM0023) Design Review (FRM0023) Design Input Design Output Design Verification Design Validation Design Transfer Product Initiation Summary (FRM0004) Customer Requirements Assessments (FRM0002) Product Performance Requirements Design Documents Mfg. Documents Testing Documents QA Documents B.O.M.s Label Prototypes Packaging Layouts Sterilization Spec (Initial) Design Verification Plan (FRM0024) Report (FRM0069) Design Validation Plan (FRM0026 Service Validation Plan (FRM0027) Report (FRM0028) Regulatory Assessment Plan (FRM0008 FRM0009) Mfg. Assessment Plan (FRM0014) System Level Requirements and Traceability Matrix (FRM0018) PROCESS VALIDATION Process Validation Protocol (FRM0072) Master Validation Plan Equipment IQ/QQ/PQ Sterilization Validation Packaging Validation Supplier Approved Sterilization Assessment Plan (FRM0017) Service Assessment Plan (FRM0021) System Level Requirements and Traceability Matrix (FRM0018) Regulatory Submissions DMR Initial Clinical Studies (if needed) Regulatory Approval DMR Final Device Master Record Release (P0008) Trademark/Patent Assessment (FRM0011) Labeling Assessment Plan (FRM0013) Initial Design and Development Plan (FRM0005) Packaging Assessment Plan (FRM0016) Supplier Assessment (FRM0015) RISK MANAGEMENT Risk Management Plan (FRM0006) Hazard/Safety Analysis (FRM0010) Design FMEA (FRM0036) Application FMEA (FRM0036) Process FMEA (FRM0019) Risk Assess and Control Workbook (P0002, FRM0036) Risk/Benefit Analysis Form (P003, FRM0037) Risk Management Report (FRM0022) Legal Release Authorization Risk Management File Project Schedule Clinical Assessment Plan (FRM0012) Materials Assessment Plan (FRM0007) Design History File Review (FRM0032) Risk Managment Design History File Design and Development Plan Design Changes

12 Design Controls (HF integration) Design Review (FRM0023) Design Review (FRM0023) Design Review (FRM0023) Design Input Design Output Design Verification Design Validation Design Transfer Product Initiation Summary (FRM0004) Customer Requirements Assessments (FRM0002) Product Performance Requirements Design Documents Mfg. Documents Testing Documents QA Documents B.O.M.s Label Prototypes Packaging Layouts Sterilization Spec (Initial) Design Verification Plan (FRM0024) Report (FRM0069) Design Validation Plan (FRM0026 Service Validation Plan (FRM0027) Report (FRM0028) 1 Exploratory Research Identifying opportunity areas via research methods 2 3 HF/E RESEARCH ACTIVITIES Competitve Bechmarking (if applicable) Field Observations Structured Interviews Video Analyses HF/E GUIDELINES Physical Ergo Standards Cognitive Ergo Standards GUI Standards (if applicable) 5 Regulatory Assessment Plan (FRM0008 FRM0009) HF Regulatory Assessment Sterilization Assessment Plan (FRM0017) Trademark/Patent Assessment (FRM0011) 8 Mfg. Assessment Plan (FRM0014) HF Sterilization Assessment Service Assessment Plan (FRM0021) Labeling Assessment Plan (FRM0013) System Level Requirements and Traceability Matrix (FRM0018) Heuristic Evaluation Label Prototypes 11 Supplier Approved Regulatory Submissions HF File FORMATIVE TESTING #1 Use-case based Tasks Ratings, Questionnaires DMR Initial System Level Requirements and Traceability Matrix (FRM0018) FORMATIVE TESTING #2 Use-case based Tasks Ratings, Questionnaires HF/E Requirements Tracing of human factors and ergonomics to product design PROCESS VALIDATION Process Validation Protocol (FRM0072) Master Validation Plan Equipment IQ/QQ/PQ Sterilization Validation Packaging Validation Clinical Studies (if needed) Regulatory Approval DMR Final Device Master Record Release (P0008) Initial Design and Development Plan (FRM0005) 4 Project Schedule Human Factors Integration Plan 6 7 HF Labeling Assessment HF Packaging Asessment Clinical Assessment Plan (FRM0012) Packaging Assessment Plan (FRM0016) Supplier Assessment (FRM0015) Materials Assessment Plan (FRM0007) 9 RISK MANAGEMENT Risk Management Plan (FRM0006) Hazard/Safety Analysis (FRM0010) Design FMEA (FRM0036) Application FMEA (FRM0036) Process FMEA (FRM0019) Risk Assess and Control Workbook (P0002, FRM0036) Risk/Benefit Analysis Form (P003, FRM0037) Risk Management Report (FRM0022) Human Error Safety & Risk Assessment 15 Human Error Safety & Risk Assessment Legal Release Authorization Risk Management File Design History File Review (FRM0032) Validation/Verification Testing HF File Risk Managment Design History File Design and Development Plan Design Changes Human Factors Integration Plan

13 Putting this into Action

14 Develop a plan Human Factors Integration Plan: Defining a path for various human factors activities and evaluations with the ultimate goal of mitigating risk one step at a time. Human Factors File: Design History File should include a human factors file. Human Factors file includes all the human factors activities, design inputs, formative and summative reports. What submissions need HF? 510K PMA NDA is your drug in a device? Will it be a part of a system?

15 Who are your users? This is KEY! What is the primary condition? What are associated comorbidities? Who are the users? Age Abilities Limitations (modality-specific) Will users be trained on your device? Training documentation? Health care professionals? Environment?

16 Identify risks early and continue to evaluate Human Error Safety Risk Assessment/uFMEA: The primary goal of a HESRA/uFMEA is to proactively identify elements of a product, system or process that present high risk of human errors that might lead to serious consequences which can be a product of perception, behavior, potential interactions, etc. Knowing your user makes this possible

17 Heuristic Evaluate Analysis early and often (expert-based) Expert-based Heuristic Analysis: Experts in human factors and usability can provide early feedback on medical device designs using: -Human factors design principles -Compliance with standards and guidelines -Setup, use, breakdown -Labeling and instructions

18 Formative Conduct Formative Testing Research Per AAMI s standard, HE75: 3.39 Formative usability testing is usability testing that is performed early with simulation and the earliest working prototypes and that explores whether usability objectives are attainable, but without strict acceptance criteria Know your user Know where your product will be used Know the user-associated risks Know your open questions and/or concerns (i.e. size, force, intuitiveness)

19 Generative Conduct Formative research Research (continued) Formative research should be iterative Iteration allows a company to focus on different topics: Instructions for use User limitations and abilities Labeling Overall ease of use Early validation of claims 5 8 participants per Unique user group 19 19

20 Formative Conduct Summative Testing Testing Per AAMI s standard, HE75: Summative usability testing is performed late in design as part of a formal verification and validation and should have formal acceptance criteria (e.g., usability objectives for human performance). Instructions for use should be final Medical device should be production-like or ready Training materials should be established Critical and non-critical use-errors should be identified participants per Unique user group

21 Conduct Summative Testing (continued) Explain the Errors What kind of use-errors? Critical failure Non-critical failure Close call Unanticipated error or action Example: 2 Patients and 1 Caregivers recorded a non-critical partial dose failure: Reasons for Partial Dose: Wet Dose resulting from holding the button Didn t wait 15 seconds after injection

22 Risk Mitigation through Human Factors Human Factors is best when leveraged proactively and iteratively Identify your risk and opportunities early on. Make informed decisions throughout and be accountable for them. Validate your product/systems and decisions. Mitigate risk one step at a time!

23 Thank you

The Complete Guide to FDA Design Controls

The Complete Guide to FDA Design Controls The Complete Guide to FDA Design Controls Jon D. Speer Founder & VP QA/RA of greenlight.guru ABOUT THE PRESENTER Jon D. Speer is the founder and VP of QA/RA of greenlight.guru 20+ years in medical device

More information

FDA Medical Device HFE Guidance

FDA Medical Device HFE Guidance W H I T E P A P E R www.makrocare.com U S FDA has established a new Draft Guidance; Applying Human Factors and Usability Engineering to Medical Devices to Optimize Safety and Effectiveness in Design. Manufacturers

More information

An Industry Perspective

An Industry Perspective Controls An Industry Perspective Presented by: Jay Gerondale Amgen Inc. Overview Why are We Here? What are Controls? Control Elements Product Development Steps Conclusion Bridging Making a Combination

More information

Design Quality. Indu Lakshman

Design Quality. Indu Lakshman Design Quality Indu Lakshman Overview New product development (NPD) covers the complete process of bringing a new product to market. In commercial terms, new product development is described in the literature

More information

Rocky Mountain Regulatory Affairs Society. Elements of and Maintenance/Remediation of the Design History File (DHF) March 15, 2017

Rocky Mountain Regulatory Affairs Society. Elements of and Maintenance/Remediation of the Design History File (DHF) March 15, 2017 Rocky Mountain Regulatory Affairs Society Elements of and Maintenance/Remediation of the Design History File (DHF) March 15, 2017 Design History File Presenters: Lee Travis Design Solutions Jim Tartarini

More information

HUMAN FACTORS ENGINEERING: DESIGN OF MEDICAL DEVICES

HUMAN FACTORS ENGINEERING: DESIGN OF MEDICAL DEVICES HUMAN FACTORS ENGINEERING: DESIGN OF MEDICAL DEVICES Chapter 5 Prof. Yasser Mostafa Kadah Managing the risk of use error Reports compiled by the Food and Drug Administration (FDA) indicate that as many

More information

Pre-Clinical Testing for Devices and Diagnostics

Pre-Clinical Testing for Devices and Diagnostics Pre-Clinical Testing for Devices and Diagnostics Larry O. Blankenship Evergreen Research, Inc. April, 2016 1 Many Levels, Many Approaches The requirements differ dramatically by class and category and

More information

Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products

Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products DR. RICK WEDGE 12 MAR 2018 Overview Definitions Current Regulatory Landscape Design Controls Risk Management

More information

BCPE CORE COMPETENCIES

BCPE CORE COMPETENCIES BCPE CORE COMPETENCIES The following Core Competencies is the exam specification, listing the critical tasks necessary for an early career professional (minimum 3 years of experience) to show competence

More information

Role of Human Factors Engineering in Medical Products Regulatory Reviews and Research

Role of Human Factors Engineering in Medical Products Regulatory Reviews and Research Role of Human Factors Engineering in Medical Products Regulatory Reviews and Research FDA Small Business Regulatory Education for Industry (REdI) Burlingame, CA May 15, 2018 Kimberly Kontson, Ph.D. Biomedical

More information

Re: Docket No. FDA-2015-D-4848: Human Factors Studies and Related Clinical Considerations in Combination Product Design and Development

Re: Docket No. FDA-2015-D-4848: Human Factors Studies and Related Clinical Considerations in Combination Product Design and Development May 3, 2016 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2015-D-4848: Human Factors Studies and Related Clinical Considerations

More information

ISO FDA QSR. ISO and FDA QSR: A Step by Step Guide to Complying with Medical Device QMS Requirements

ISO FDA QSR. ISO and FDA QSR: A Step by Step Guide to Complying with Medical Device QMS Requirements ISO 13485 FDA QSR ISO 13485 and FDA QSR: A Step by Step Guide to Complying with Medical Device QMS Requirements Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Introduction 4 QMS Philosophy

More information

Global Regulatory Affairs

Global Regulatory Affairs Navigating the Regulatory Landscape for Combination Products Presented by: Becky Leibowitz, Ph.D. Associate Director, RA-CMC, Medical Devices & Combination Products Janssen Research & Development, LLC

More information

The Foundation for Professional Ergonomics (FPE) Criteria for the Dieter W. Jahns Student Practitioner Award

The Foundation for Professional Ergonomics (FPE) Criteria for the Dieter W. Jahns Student Practitioner Award P. O. Box 2176 Bellingham, WA 98227-2176 TIN: 20-1575494 www.ergofoundation.org The Foundation for Professional Ergonomics (FPE) Criteria for the Dieter W. Jahns Student Practitioner Award The Dieter W.

More information

Leading Practices on Compliance Series: Design History File (DHF): Tips for Creating a Successful DHF Tuesday, November 27, :00 1:00 pm Eastern

Leading Practices on Compliance Series: Design History File (DHF): Tips for Creating a Successful DHF Tuesday, November 27, :00 1:00 pm Eastern Leading Practices on Compliance Series: (DHF): Tips for Creating a Successful DHF Tuesday, November 27, 2012 12:00 1:00 pm Eastern Jack Ward, Senior Director Myraqa, Inc. Leading Practices on Compliance

More information

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA Implement Effective Computer System Validation Noelia Ortiz, MME, CSSGB, CQA Session Outline 1 2 3 4 5 Understanding Regulations and Guidelines Pertaining to Computer Systems Integrate SDLC and GAMP 5

More information

Meeting FDA Standards For Medical Device Quality: An Outof-the-box

Meeting FDA Standards For Medical Device Quality: An Outof-the-box Meeting FDA Standards For Medical Device Quality: An Outof-the-box PLM Approach PTC s Medical Device Value-Ready Deployment TM Offering: Overview May 2016 Companies perceive that the regulatory framework

More information

Automated System Validation By: Daniel P. Olivier & Curtis M. Egan

Automated System Validation By: Daniel P. Olivier & Curtis M. Egan Automated System Validation By: Daniel P. Olivier & Curtis M. Egan In today s technical environment validation practices are both a requirement and an important tool in the medical and pharmaceutical industry.

More information

V&V Best Practices. CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. SUTTONSCREEK.COM

V&V Best Practices. CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. SUTTONSCREEK.COM V&V Best Practices CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. Solving the problem of Complexity. 21CFR820.30 & FDA Guidance INCOSE System Engineering Handbook

More information

MEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS

MEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS MEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS Human factors engineering (HFE) is now an essential requirement for all new drug delivery combination product approvals to ensure devices

More information

PAI Inspections, Observations and Data Integrity

PAI Inspections, Observations and Data Integrity PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November

More information

Quality Risk Management and Submission Strategies for Breakthrough Therapies

Quality Risk Management and Submission Strategies for Breakthrough Therapies Quality Risk Management and Submission Strategies for Breakthrough Therapies IFPAC/Washington DC January 22, 2014 Sarah Pope Miksinski, Ph.D. Acting Director, Division of New Drug Quality Assessment 2

More information

Quality System Regulation (QSR) Training

Quality System Regulation (QSR) Training Quality System Regulation (QSR) Training Or How to Ensure Development, Production and Sale of Safe, Effective, Consistent Product FDLI February 2003 Overview QSR History, Purpose and Scope Changes from

More information

PDPServices. Medical Device Design Solutions. Whitney Moore, Director of Program Development. Aaron Lee, Manager of Quality and Regulatory

PDPServices. Medical Device Design Solutions. Whitney Moore, Director of Program Development. Aaron Lee, Manager of Quality and Regulatory PDPServices TM Medical Device Design Solutions Whitney Moore, Director of Program Development Aaron Lee, Manager of Quality and Regulatory Ron Koronkowski, Director of Quality and Regulatory 2 PDPServices

More information

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017 Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017 F. Wildenhahn, Human Factors Engineering & U. Grauschopf, Head

More information

Contact:: (609) Details please visit our website:

Contact:: (609) Details please visit our website: SunGen Pharma aims to create a healthier future for patients while increasing shareholder value through the development and introduction of quality, affordable generic products by experienced, passionate

More information

Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program?

Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program? Voluntary Pilot Meeting Preview: How will CDRH apply assessments in the voluntary program? Cisco Vicenty Case for Quality Program Manager Center for Devices and Radiological Health U.S. Food and Drug Administration,

More information

Software Testing Level Part 2. Adam Hendra Brata

Software Testing Level Part 2. Adam Hendra Brata Software Testing Level Part 2 Adam Hendra Brata Agenda : Part 2 Acceptance Testing Alpha Beta 2 Testing Activities Object Design Document System Design Document Requirements Analysis Document Client Expectation

More information

QUALITY SYSTEMS INSPECTIONS TECHNIQUE

QUALITY SYSTEMS INSPECTIONS TECHNIQUE QUALITY SYSTEMS INSPECTIONS TECHNIQUE Notice: This draft document represents the Agency' current thinking on the subject of Quality System Inspections. It is provided to the public in order to stimulate

More information

[control] [data] [process] [strategy] [partners] [testing] [validation]

[control] [data] [process] [strategy] [partners] [testing] [validation] [control] [data] [process] A practical approach to using Agile in an FDA regulated environment environment Jim Gunning Director, Q-CSV Johnson & Johnson [strategy] [partners] [testing] [validation] Agenda

More information

The Quality System Regulation

The Quality System Regulation Integrating Medical Device Product Development, Design for Six Sigma and Quality Systems Regulation Part II By Dr Vinny Sastri This article was originally published in Medical Device & Diagnostic Industry,

More information

Current Trends at FDA: Implications for Data Requirements

Current Trends at FDA: Implications for Data Requirements Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable

More information

GAMP5 Validation for Dynamics 365

GAMP5 Validation for Dynamics 365 GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning

More information

Revision no: 01 Date: Global Supplier Quality Assurance Network

Revision no: 01 Date: Global Supplier Quality Assurance Network Title: H-APQP Template Manual Purpose and Scope This document is aimed at internal and external stakeholders to describe the use of the H-APQP Template. Contents Introduction H-APQP... 2 1. Planning and

More information

Copyright GCI, LLC Remediation of Legacy Medical Devices

Copyright GCI, LLC Remediation of Legacy Medical Devices Copyright GCI, LLC. 2016 Remediation of Legacy Medical Devices Copyright GCI, LLC. 2016 What Drives Legacy Remediation? Proactive Recertification / CE Mark Audit Readiness M&A / Due Diligence Reactive

More information

SOFTWARE APPS AS MEDICAL DEVICES. The Regulatory Landscape 2015 WHITE PAPER WHITE PAPER PRODUCED BY MAETRICS

SOFTWARE APPS AS MEDICAL DEVICES. The Regulatory Landscape 2015 WHITE PAPER WHITE PAPER PRODUCED BY MAETRICS WHITE PAPER SOFTWARE APPS AS MEDICAL DEVICES The Regulatory Landscape 2015 WHITE PAPER PRODUCED BY MAETRICS For more information, please contact: USA Office: +1 317 706 1493 UK Office: +44 115 921 6200

More information

WARNING LETTER CMS #

WARNING LETTER CMS # Office of Medical Device and Radiological Health Operations Division 3/West 19701 Fairchild Irvine, CA 92612 WARNING LETTER CMS # 558900 UNITED PARCEL SERVICE OVERNIGHT DELIVERY November 20, 2018 Michael

More information

Quality From a Regulatory Reviewer Perspective. UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices

Quality From a Regulatory Reviewer Perspective. UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices U. S. Department of Health and Human Services Quality From a Regulatory Reviewer Perspective UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices July 16,

More information

ZOLL Document Number: 90E0021 Page 6 of 50 QUALITY SYSTEM MANUAL ZOLL Document Number: 90E0021 Page 7 of 50 1 EXECUTIVE MANAGEMENT APPROVAL... 10 2 INTRODUCTION... 11 3 QUALITY SYSTEM... 12 3.1 QUALITY

More information

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval UN Prequalification of Medicines, Diagnostics and Vaccines 6 th Consultative Stakeholder Meeting 4 April

More information

Medical Device Product Development for Startups

Medical Device Product Development for Startups Medical Device Product Development for Startups - The Bitter Pill AZBIO WEEK / CEI 8/19/2016 ERIC MILLER PADT, INC. Agenda Introduction Medical Device Development Fundamentals The Design Process Manufacturing

More information

QUALITY ASSURANCE PLAN OKLAHOMA DEPARTMENT OF HUMAN SERVICES ENTERPRISE SYSTEM (MOSAIC PROJECT)

QUALITY ASSURANCE PLAN OKLAHOMA DEPARTMENT OF HUMAN SERVICES ENTERPRISE SYSTEM (MOSAIC PROJECT) QUALITY ASSURANCE PLAN OKLAHOMA DEPARTMENT OF HUMAN SERVICES ENTERPRISE SYSTEM (MOSAIC PROJECT) MOSAIC Quality Assurance Plan v04.02 Prepared by: Approved by: QUALITY ASSURANCE PLAN APPROVALS QA/QC Program

More information

WORK PLAN AND IV&V METHODOLOGY Information Technology - Independent Verification and Validation RFP No IVV-B

WORK PLAN AND IV&V METHODOLOGY Information Technology - Independent Verification and Validation RFP No IVV-B 1. Work Plan & IV&V Methodology 1.1 Compass Solutions IV&V Approach The Compass Solutions Independent Verification and Validation approach is based on the Enterprise Performance Life Cycle (EPLC) framework

More information

Optimizing Device Interoperability Through Model-Based Systems Engineering

Optimizing Device Interoperability Through Model-Based Systems Engineering Optimizing Device Interoperability Through Model-Based Systems Engineering Presenter: Brett Malone, Ph.D. Sept 8, 2011 Summary: This presentation focuses on applying the concepts of systems engineering

More information

Software Project & Risk Management Courses Offered by The Westfall Team

Software Project & Risk Management Courses Offered by The Westfall Team Software Project & Risk Management is a 5-day course designed to provide a knowledge base and practical skills for anyone interested in implementing or improving Software Project and Risk Management techniques

More information

How to Get ISO Certified

How to Get ISO Certified People frequently ask me where to locate information about ISO 13485, so this whitepaper was written specifically to address their needs, as well as review in detail the six steps to preparing for ISO

More information

Software in Medical Devices

Software in Medical Devices Software in Medical Devices Module 1: Regulations, Guidance, Standards, and Terminology Planning Jeremy Jensen Fellow Software Quality Engineer Boston Scientific Irma Sandoval-Watt Senior Regulatory Strategist

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

RISK MANAGEMENT AND DESIGN CONTROL. PRACTICAL SOLUTION F. Akelewicz 03/06

RISK MANAGEMENT AND DESIGN CONTROL. PRACTICAL SOLUTION F. Akelewicz 03/06 RISK MANAGEMENT AND DESIGN CONTROL All rights reserved. No part of this work covered by the copyright hereon may be reproduced or used in any form or by any means including graphic, electronic, or mechanical,

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

Business Analysis Essentials

Business Analysis Essentials Understand the business analyst's role and responsibilities in a successful project. In this introductory course, you'll delve into the role and responsibilities of the business analyst (BA)- the communication

More information

Incorporating FDA Regulatory Thinking into Plans for Medical Devices

Incorporating FDA Regulatory Thinking into Plans for Medical Devices Incorporating FDA Regulatory Thinking into Plans for Medical Devices Ken Holroyd, MD, MBA Medical Director, Center for Technology Transfer and Commercialization Assistant Vice Chancellor for Research June

More information

Service Oriented Architecture (SOA) Implications to End-to-End Assessment

Service Oriented Architecture (SOA) Implications to End-to-End Assessment Service Oriented Architecture (SOA) Implications to End-to-End Assessment Brian Eleazer Brian Hall Robert Kohout Joint Systems Integration Center U.S. Joint Forces Command 757-203-4421 / 4453 / 7598 John.eleazer@jsic.jfcom.mil

More information

Development of the Patient Safety Incident Management System (DPSIMS): Private Beta

Development of the Patient Safety Incident Management System (DPSIMS): Private Beta Development of the Patient Safety Incident Management System (DPSIMS): Private Beta Briefing pack for prospective pilot sites that currently use a local risk management system to report to the NRLS July

More information

Expert Design & Support Engineer to work within Diagnostics Division. Technical Specifications

Expert Design & Support Engineer to work within Diagnostics Division. Technical Specifications Expert Design & Support Engineer to work within Diagnostics Division Technical Specifications Version 1.0 Date: 17/07/2012 Name Affiliation Author V UDINTSEV CHD / DIAGNOSTICS Reviewers M WALSH CHD/ DIAGNOSTICS

More information

Medication errors: Development of prevention strategies for medicines and medical devices

Medication errors: Development of prevention strategies for medicines and medical devices Medication errors: Development of prevention strategies for medicines and medical devices Laurent Auclert Chairman of the PharmacoVigilance Committee EFPIA 1 Medication errors defined as occurring while

More information

EBOOK THE ULTIMATE GUIDE TO DESIGN CONTROLS FOR MEDICAL DEVICE COMPANIES JON SPEER, FOUNDER & VP QA/RA

EBOOK THE ULTIMATE GUIDE TO DESIGN CONTROLS FOR MEDICAL DEVICE COMPANIES JON SPEER, FOUNDER & VP QA/RA EBOOK THE ULTIMATE GUIDE TO DESIGN CONTROLS FOR MEDICAL DEVICE COMPANIES JON SPEER, FOUNDER & VP QA/RA THE ULTIMATE GUIDE TO DESIGN CONTROLS FOR MEDICAL DEVICE COMPANIES TABLE OF CONTENTS 2. What s in

More information

DESIGN CONTROL. Your Logo Here. Operational Procedure: EOP Rev.: A Pg. 1 1 of 7 DISTRIBUTION

DESIGN CONTROL. Your Logo Here. Operational Procedure: EOP Rev.: A Pg. 1 1 of 7 DISTRIBUTION Your Logo Here DESIGN CONTROL Operational Procedure: EOP-04-01 Rev.: A Pg. 1 1 of 7 DISTRIBUTION President Purchasing Human Resources Design Engineering Service Quality Assurance Production Marketing Quality

More information

Reducing the Time to Market with an eclinical System

Reducing the Time to Market with an eclinical System Reducing the Time to Market with an eclinical System Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright

More information

Data Transparency and Quality Metrics

Data Transparency and Quality Metrics Data Transparency and Quality Metrics Ann Ferriter Division of Analysis and Program Operations Office of Compliance Center for Devices and Radiological Health Why are we interested in transparency? What

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Medical Device Product Questionnaire This questionnaire is used to collect information from vendors with regards to medical devices that fall in any of the

More information

Florida State University Policy 7-IRB-

Florida State University Policy 7-IRB- Florida State University Policy 7-IRB- Title of Policy: Institutional Review Board Jurisdiction/Applicability Responsible Executive: Gary K. Ostrander Approving Official: Gary K. Ostrander Effective Date:

More information

M3 Playbook Guidance. 1.1 Establish Initial Customer PMO and Processes. Human Resources (HR)/Staffing Plan

M3 Playbook Guidance. 1.1 Establish Initial Customer PMO and Processes. Human Resources (HR)/Staffing Plan M3 Playbook Guidance Phase 1: Readiness This guidance is intended for use by organizations to confirm and validate that their plans are comprehensive and have adequate level of detail for proper migration

More information

Process Transfer Excellence Basis for a fast and successful project

Process Transfer Excellence Basis for a fast and successful project Process Transfer Excellence Basis for a fast and successful project Dr. Stefan Minning, Dr. Lars Dreesmann Boehringer Ingelheim Pharma GmbH & Co. KG Excellence in Biopharmaceutical Process Transfer Boehringer

More information

THE REGULATORY PROCESS

THE REGULATORY PROCESS THE REGULATORY PROCESS A MANUFACTURER S PERSPECTIVE QRC Consulting Inc Copyrighted 508-259-7374 2 Medical Devices Catheters, monitors, heart valves, etc Cotton Swabs Incontinence pads Tongue depressors

More information

Medical Device Directive

Medical Device Directive Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,

More information

COMBINATION PRODUCTS IMPLEMENTATION REQUIREMENTS. OF cgmp. Lisa A. Hornback Editor.

COMBINATION PRODUCTS IMPLEMENTATION REQUIREMENTS. OF cgmp. Lisa A. Hornback Editor. COMBINATION PRODUCTS IMPLEMENTATION OF cgmp REQUIREMENTS Lisa A. Hornback Editor CONTENTS FOREWORD Richard Levy viii 1 INTRODUCTION 1 Lisa A. Hornback References 6 About the Author 6 2 QUALITY SYSTEM DEVELOPMENTS

More information

Clinical Data in Business Intelligence

Clinical Data in Business Intelligence Paper DV07 Clinical Data in Business Intelligence Mike Collinson, Oracle Heath Sciences Consulting (HSC), Reading, UK ABSTRACT Clinical organizations are under increasing pressure to execute clinical trials

More information

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA QSR (21 CFR Part 820) ISO 13485:2016 820.1 Scope 1 Scope 2 Normative References 820.3 Definitions 3 Terms and Definitions

More information

Chapter 9. Human Factors Informed Failure Mode and Effects Analysis

Chapter 9. Human Factors Informed Failure Mode and Effects Analysis Chapter 9. Human Factors Informed Failure Mode and Effects Analysis Section 9.1. Setting the Stage Failure Mode and Effects Analysis (FMEA) is an engineering method for proactively assessing vulnerabilities

More information

Clinical Data Standards & Automation

Clinical Data Standards & Automation Clinical Data Standards & Automation PhUSE 2007 Author: Giri Balasubramanian Company Name: Kinship Technologies Pvt. Ltd., Table of Contents EXECUTIVE SUMMARY... 3 1.0 INTRODUCTION... 4 2.0 WHY AUTOMATION?...

More information

Intuitive Lab Management from Bench to Boardroom

Intuitive Lab Management from Bench to Boardroom Intuitive Lab Management from Bench to Boardroom Clarity LIMS features are bundled into editions. Flags indicate the features contained within each edition. INTRODUCTION As a genomics or mass spec lab,

More information

CDRH Regulation Medical Device Software Validation

CDRH Regulation Medical Device Software Validation CDRH Regulation Medical Device Software Validation Do-Hyun Kim, Ph.D, Ph.D CEO, BT Solutions, Inc. South Korea CEO, Solutions 4BT, LLC, USA The Transformation of Medical Device Industry for Thailand 4.0:

More information

CMC Strategy Forum Europe 2016

CMC Strategy Forum Europe 2016 Science-based Development & Licensing of Combination Products Focus on High Concentration Monoclonal Antibody Solutions in Prefilled Syringes or Prefilled Pens Serge Mathonet, Sanofi Global Regulatory

More information

ehealth Suisse Checklists Addendum to the guideline for app developers, manufacturers and distributors

ehealth Suisse Checklists Addendum to the guideline for app developers, manufacturers and distributors ehealth Suisse Checklists Addendum to the guideline for app developers, manufacturers and distributors Bern, 2 March 2018 Page 1 Legal notice ehealth Suisse, Swiss Competence and Coordination Centre of

More information

PharmaPerspectiveonCDx. DrGillian Ellison

PharmaPerspectiveonCDx. DrGillian Ellison PharmaPerspectiveonCDx DrGillian Ellison Pharma Perspective Need for CDx Partnering with Dx company Co- development Launch readiness & LCM Need for CDx Drug development Drug development is a challenging

More information

ISO 13485:2016. What s in it - and what does it mean?

ISO 13485:2016. What s in it - and what does it mean? ISO 13485:2016 What s in it - and what does it mean? QAdvis key competence areas Turn key quality systems Sharepoint based Digital signatures Efficient and lean Validated and compliant QMS in-the cloud

More information

CONSIDERATIONS OF CONTINUOUS MANUFACTURING PROCESSES

CONSIDERATIONS OF CONTINUOUS MANUFACTURING PROCESSES LCDR Patric Klotzbuecher U.S. FDA/Office of Regulatory Affairs/New York District 3 rd FDA/PQRI Conference on Advancing Product Quality March 22 24, 2017 CGMP AND REGULATORY CONSIDERATIONS OF CONTINUOUS

More information

Independent Verification and Validation (IV&V)

Independent Verification and Validation (IV&V) Independent Verification and Validation (IV&V) 12 th Annual NDIA CMMI Conference November 2012 - Denver, CO The MITRE Corporation The author s affiliation with The MITRE Corporation is provided for identification

More information

The Role of a Clinical Statistician in Drug Development By: Jackie Reisner

The Role of a Clinical Statistician in Drug Development By: Jackie Reisner The Role of a Clinical Statistician in Drug Development By: Jackie Reisner Types of studies within clinical development Phase I Phase II Phase III Phase IV Phase I First Human Dose (FHD) Young healthy

More information

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical

More information

PMP Exam Preparation Course Project Scope Management

PMP Exam Preparation Course Project Scope Management Project Scope Management 1 Product Scope Product scope The features and functions that are to be included in your products or service or result of the project. Completion is measured against the product

More information

Requirement Engineering. L3 The requirement study. Change is constant. Communication problem? People are hard to understand!

Requirement Engineering. L3 The requirement study. Change is constant. Communication problem? People are hard to understand! Requirement Engineering L3 The requirement study Fang Chen Requirement are ubiquitous part of our lives Understand the requirement through communication Requirement Creation Communication problem? People

More information

Copyright Software Engineering Competence Center

Copyright Software Engineering Competence Center Copyright Software Engineering Competence Center 2012 1 Copyright Software Engineering Competence Center 2012 5 These are mapped categories to the waste categories of manufacturing. An excellent overview

More information

Lightning Protection Systems

Lightning Protection Systems Lightning Protection Systems DESIGN & MANUFACTURE FOR THE WIND TURBINE INDUSTRY PolyTech is a full service engineering and manufacturing business specialising in lightning protection systems primarily

More information

Human Factors Engineering HHP8102

Human Factors Engineering HHP8102 Human Factors Engineering HHP8102 Professor Mare Teichmann Copyright 2010 Mare Teichmann, Tallinn University of Technology, Institute of Industrial Psychology. All rights reserved The course: Human Factors

More information

PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements

PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements Doug Mead, Sr. Director, CMC RA, Devices and Combination

More information

Inspection-Ready IRT. Valarie Higgins President & Managing Director Almac Clinical Technologies.

Inspection-Ready IRT. Valarie Higgins President & Managing Director Almac Clinical Technologies. Inspection-Ready IRT Valarie Higgins President & Managing Director Almac Clinical Technologies www.almacgroup.com 2 Biologics License Application and the IRT Provider IRT 3 Agenda Why is IRT Becoming an

More information

GETTING THE MOST OUT OF YOUR WOOLWORTHS SUPPLIER AUDIT

GETTING THE MOST OUT OF YOUR WOOLWORTHS SUPPLIER AUDIT GETTING THE MOST OUT OF YOUR WOOLWORTHS SUPPLIER AUDIT Objectives of a WW Supplier Audit: How well a supplier conforms to the standard requirements Safe, quality products Brand protection Additional Supplier

More information

Quality Manual ISO 9001:2008 ISO 9001:2015

Quality Manual ISO 9001:2008 ISO 9001:2015 Quality Manual ISO 9001:2008 ISO 9001:2015 SAE CIRCUITS, INC. 4820 63 rd Street Suite 100 Boulder, CO 80301 USA www.saecircuits.com Table of Contents 1. Company Information 3 2. QMS Scope and Exclusions

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

Information Technology Independent Verification and Validation

Information Technology Independent Verification and Validation Florida Department of Management Services Information Technology Independent Verification and Validation RFP No. Work Plan and Methodology ; 2:30 PM EST 2150 River Plaza Drive Suite 380 Sacramento California

More information

Medication Errors: An FDA Perspective

Medication Errors: An FDA Perspective Medication Errors: An FDA Perspective Carol Holquist, RPh Director, DMEPA CDER/OSE/OMEPRM European Union Regulatory Workshop on Medication Errors March 1, 2013 1 Background Historically, nomenclature and

More information

Engineering support in IC antenna design, thermal and hydraulic analysis. Contract Technical Specifications

Engineering support in IC antenna design, thermal and hydraulic analysis. Contract Technical Specifications Engineering support in IC antenna design, thermal and hydraulic analysis Contract Technical Specifications Version 1.1 Date: 02/07/2012 Name Affiliation Author P. Lamalle CHD/HCD/IC Reviewers B. Beaumont

More information

Test and Control Article Characterization for Medical Devices. Amy Schade, RQAP-GLP Director Corporate Compliance

Test and Control Article Characterization for Medical Devices. Amy Schade, RQAP-GLP Director Corporate Compliance for Amy Schade, RQAP-GLP Director Corporate Compliance Disclaimer» This presentation is not intended to encompass all of the requirements of the FDA, EPA, OECD or other regulatory programs for all types

More information

Continuous Manufacturing Achieving the Vision of Modernizing Pharmaceutical Manufacturing

Continuous Manufacturing Achieving the Vision of Modernizing Pharmaceutical Manufacturing Continuous Manufacturing Achieving the Vision of Modernizing Pharmaceutical Manufacturing FDA-AIChE Workshop on Adopting Continuous Manufacturing February 29 March 1, 2016 Rapti Madurawe, Ph.D. Acting

More information

ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly

ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly THE PROBLEM WITH COA The quality of collected patient data, study timelines and study costs are influenced by a number of factors,

More information

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case 701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers

More information

The Device Side of Combination Products

The Device Side of Combination Products The Device Side of Combination Products Technical and Regulatory Challenges in Life Cycle Management Bob Laughner Associate Director, Combination Products 04 May 2016 What are combination products? Combination

More information

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper Prevent Quality System Deficiencies by Conducting Effective Internal Audits Whitepaper An internal audit system is one of the most effective ways to monitor, analyze, control, and improve quality management

More information